Fifth Third Bancorp Purchases 109,308 Shares of Bath & Body Works, Inc. $BBWI

Fifth Third Bancorp raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 15,309.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 110,022 shares of the company’s stock after buying an additional 109,308 shares during the period. Fifth Third Bancorp’s holdings in Bath & Body Works were worth $2,054,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in BBWI. Parallel Advisors LLC increased its position in shares of Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after acquiring an additional 567 shares during the period. Meeder Asset Management Inc. boosted its holdings in shares of Bath & Body Works by 28.5% during the fourth quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after purchasing an additional 637 shares during the period. State of Wyoming grew its stake in shares of Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after purchasing an additional 661 shares during the last quarter. Vident Advisory LLC grew its stake in shares of Bath & Body Works by 2.8% in the second quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after purchasing an additional 692 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its holdings in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. Institutional investors own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Piper Sandler initiated coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price target for the company. Barclays cut their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 28th. The Goldman Sachs Group cut Bath & Body Works from a “neutral” rating to a “sell” rating and reduced their target price for the company from $23.00 to $19.00 in a research note on Wednesday, July 8th. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Finally, Weiss Ratings upgraded shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $22.00.

Bath & Body Works Price Performance

BBWI stock opened at $20.03 on Thursday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $33.67. The firm has a 50-day moving average of $19.73 and a 200 day moving average of $20.45. The company has a market cap of $4.04 billion, a P/E ratio of 5.63, a PEG ratio of 2.00 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. During the same period in the previous year, the firm posted $0.49 EPS. The business’s revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities research analysts expect that Bath & Body Works, Inc. will post 2.63 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is presently 22.47%.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.